MedAlliance enrols first patient in FDA IDE study of SELUTION SLR
The SELUTION SLR was granted CE Mark approval for the treatment of peripheral artery disease in February 2020…
13 Jul 20
The SELUTION SLR was granted CE Mark approval for the treatment of peripheral artery disease in February 2020…
13 Jul 20
PIONEER-III clinical trial is evaluating the BuMA Supreme Drug-Eluting Coronary Stent (DES) and the results will be used…
10 Jul 20
As a result of the pandemic, healthcare has seen a significant increase in the use of telemedicine among…
08 Jul 20
LINQ II is a small wireless ICM intended for patients with abnormal heart rhythms who experience infrequent symptoms…
08 Jul 20
Previously Hemovent closed a $5.2 million Series B round on the expectation of a regulatory approval of its…
07 Jul 20
The Gallant implantable cardioverter defibrillator family of devices feature bluetooth capability to enable connection between patients and doctors
07 Jul 20
New data on successful transplantations for high-risk profile donor hearts presented at the American Transplant Congress
03 Jul 20
inHEART is a spin-off from IHU Liryc and Inria, two worldwide leading centers respectively in cardiac electrophysiology and…
29 Jun 20
REDUCER-I is a multi-centre, international, three-arm prospective and retrospective observational clinical study of Neovasc Reducer to treat refractory…
26 Jun 20
The partnership will combine the latest innovations in technology for integrated cardiovascular solutions to deliver on the quadruple…